Barclays’s Cidara Therapeutics CDTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
29,624
+29,596
| +105,700% | +$1.44M | ﹤0.01% | 2440 |
|
|
2025
Q1 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 4301 |
|
|
2022
Q3 | – | Sell |
-44,185
| Closed | -$22K | – | 4650 |
|
|
2022
Q2 | $22K | Sell |
44,185
-3,240
| -7% | -$1.61K | ﹤0.01% | 4045 |
|
|
2022
Q1 | $39K | Hold |
47,425
| – | – | ﹤0.01% | 4095 |
|
|
2021
Q4 | $60K | Sell |
47,425
-4,906
| -9% | -$6.21K | ﹤0.01% | 3012 |
|
|
2021
Q3 | $117K | Buy |
52,331
+910
| +2% | +$2.04K | ﹤0.01% | 3167 |
|
|
2021
Q2 | $104K | Sell |
51,421
-689
| -1% | -$1.39K | ﹤0.01% | 3126 |
|
|
2021
Q1 | $138K | Buy |
52,110
+40,479
| +348% | +$107K | ﹤0.01% | 3267 |
|
|
2020
Q4 | $23K | Sell |
11,631
-4,365
| -27% | -$8.63K | ﹤0.01% | 3358 |
|
|
2020
Q3 | $46K | Sell |
15,996
-2,298
| -13% | -$6.61K | ﹤0.01% | 3324 |
|
|
2020
Q2 | $68K | Buy |
+18,294
| New | +$68K | ﹤0.01% | 3280 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | – | – | 3888 |
|
|
2019
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4140 |
|
|
2018
Q2 | – | Sell |
-300
| Closed | -$1K | – | 4204 |
|
|
2018
Q1 | $1K | Sell |
300
-12,300
| -98% | -$41K | ﹤0.01% | 4120 |
|
|
2017
Q4 | $86K | Buy |
12,600
+3,200
| +34% | +$21.8K | ﹤0.01% | 3082 |
|
|
2017
Q3 | $76K | Sell |
9,400
-11,490
| -55% | -$92.9K | ﹤0.01% | 2804 |
|
|
2017
Q2 | $157K | Buy |
20,890
+20,831
| +35,307% | +$157K | ﹤0.01% | 2563 |
|
|
2017
Q1 | $0 | Buy |
+59
| New | – | ﹤0.01% | 4026 |
|
|
2016
Q4 | – | Sell |
-93
| Closed | -$1K | – | 3827 |
|
|
2016
Q3 | $1K | Buy |
+93
| New | +$1K | ﹤0.01% | 3718 |
|
|
2015
Q4 | – | Sell |
-25
| Closed | – | – | 3259 |
|
|
2015
Q3 | $0 | Sell |
25
-67
| -73% | – | ﹤0.01% | 3961 |
|
|
2015
Q2 | $1K | Buy |
+92
| New | +$1K | ﹤0.01% | 3998 |
|